Novartis also was boosted by an upgrade, reports Val Brickates Kennedy for MarketWatch.
The WisdomTree International Health Care (DBR) has been trading above 3% so far today, but is down 6.5% year-to-date. GSK is 9.5%, Novartis is 6.9% and Takeda is 3.4%.
The iShares S&P Global Healthcare (IXJ) is down slightly in early trading. GSK is 5.6% and Novartis is 6.6%. The fund is down 11.7% year-to-date.